Skip to content
DataLookout
Menu

RURAL-HFNCT07946679

Leveraging Telemedicine to Improve Guideline-Directed Medical Therapy Use and Outcomes Among Rural Patients With Heart Failure

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Hierarchical Composite of All-Cause Mortality, Heart Transplantation or Ventricular-Assist Device, Heart Failure Hospitalizations, and Improvement in Kansas City Cardiomyopathy Questionnaire Score
Timeframe: Baseline to 180 days

Secondary (5)

Proportion of participants achieving optimal or maximally tolerated GDMT
Heart Failure Collaboratory GDMT composite score
Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score
Change in mean daily step count
Implementation outcomes assessed using the RE-AIM framework

Arms and interventions

Remote patient monitoring + NT-proBNP & provider-to-provider supportExperimental

Participants receive a cellular-connected device kit (weight scale, blood pressure and heart rate monitor, and wrist-worn activity tracker) with remote monitoring for 90 days following enrollment. In addition, the study team recommends NT-proBNP and basic metabolic panel testing at weeks 2 and 6, which the participant's outpatient care team may obtain as part of routine clinical care. The study team reviews biometric and laboratory data at least weekly and delivers specific, evidence-based GDMT initiation and titration recommendations (drug, dose, titration schedule, and laboratory monitoring instructions) to the participant's outpatient care team through asynchronous electronic health record communication at one-to-two-week intervals throughout the 90-day titration period. At least one synchronous video or telephone consultation is offered, with additional consultations available at the provider's preference. The participant's outpatient care team implements all medication changes.

Remote patient monitoring (RPM) aloneActive comparator

Participants receive the same cellular-connected device kit with remote monitoring for 90 days following enrollment. The study team may send safety alerts from remote monitoring to the participant's outpatient provider, without recommendations for GDMT up-titration. No recommendations for NT-proBNP testing and GDMT titration recommendations will be sent out by the study team. GDMT management, outpatient follow-up, and laboratory monitoring are delivered according to standard community practice by the participant's primary care provider or cardiologist.

Other: Provider-to-provider telehealth GDMT titration support

Devices: Cellular-connected remote patient monitoring

Sites

2 sites in 1 country